Search
for
Sort by
Research 31–60 of 1000+
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- The role of pre-operative androgen stimulation in hypospadias surgery.
- Minoxidil oral en alopecia androgénica: estudio retrospectivo acerca de su seguridad en práctica clínica real
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Estudio comparativo de dos complementos alimenticios inhibidores de la 5a-reductasa en la alopecia androgénica femenina
- Pengaruh Terapi Kombinasi 5 Titik Akupunktur Terhadap Penurunan Jumlah Rambut Rontok (Alopecia Androgenetic) Pada Wanita Usia 31-50 Tahun
- 105 Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Genital Arousal Disorder
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Il trattamento con metformina e clomifene citrato nelle donne con sindrome dell’ovaio policistico e infertilità
- Pharmacology of anabolic steroids
- Characterization of X-Linked SNP genotypic variation in globally distributed human populations
- Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: a case report in the context of current best clinical practice
- Anabolic–Androgenic Steroids and Brain Damage: A Review of Evidence and Medico-Legal Implications
- The Level of Copper in Hair Androgenic Alopecia
- Virilizing insulinoma
- UTILIDADES DE LA ESPIRONOLACTONA COMO FÁRMACO ANTIANDROGÉNICO
- Cutaneous manifestations of polycystic ovary syndrome
- The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial
- [Commentary] The Polyfollicular Anovulatory Androgenic Syndrome: A New Label for an Old Syndrome
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- Androgens in women
- Системная терапия больных андрогенетической алопецией
- Systemic therapy of androgenic alopecia
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Female pattern hair loss
- Trichoscopy update 2011
- Endocrinology of Transgender Medicine